Early antiretroviral HIV treatments to be subsidised

From 1 April, restrictions preventing subsidised antiretroviral therapy for some HIV positive people have been lifted. Previously, treatment was only subsidised by the Pharmaceutical Benefits Scheme (PBS) once CD4 counts dropped below 500 which could mean substantial treatment delay in the many people whose CD4 counts remain stable for years.